Abstract
Giant cell tumors (GCTs) are relatively common, locally aggressive benign neoplasms of bone that demonstrate a high risk for local recurrence and an occasional propensity for metastatic dissemination [1, 2]. The sacrum is the third most common location of GCTs after the knee and distal radius and the most common location in the axial skeleton [1–4]. Most affected patients are between 20 and 40 years old, with approximately 70% of cases occurring in this age group [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dorfman HD, Czerniak B. Bone tumors. St. Louis: Mosby; 1998.
Randall RL. Giant cell tumor of the sacrum. Neurosurg Focus. 2003;15(2):E13.
Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69(1):106–14.
Ruggieri P, Mavrogenis AF, Ussia G, Angelini A, Papagelopoulos PJ, Mercuri M. Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor. Clin Orthop Relat Res. 2010;468(11):2954–61. doi:10.1007/s11999-010-1448-8.
Chen KH, Wu PK, Chen CF, Chen WM. Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage. Eur Spine J. 2015;24(10):2182–8. doi:10.1007/s00586-015-3978-y.
Leggon RE, Zlotecki R, Reith J, Scarborough MT. Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res. 2004;423:196–207.
Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am. 2006;37(1):35–51. doi:10.1016/j.ocl.2005.08.005.
Zhang K, Chen K, Zhou M, Chen H, Lu J, Yang H. Extremely large giant-cell tumor of sacrum with successful resection via posterior approach. Spine J. 2015;15(7):1684–5. doi:10.1016/j.spinee.2015.02.007.
Feigenberg SJ, Marcus Jr RB, Zlotecki RA, Scarborough MT, Berrey BH, Enneking WF. Radiation therapy for giant cell tumors of bone. Clin Orthop Relat Res. 2003;411:207–16. doi:10.1097/01.blo.0000069890.31220.b4.
Reid R, Banerjee S, Sciot R. Giant cell tumour. In: Fletcher D, Unni K, Mertens F, editors. WHO Classification of tumors. Pathology and genetics: tumors of soft tissue and bone. Lyon: IARC Press; 2002. p. 310–2.
Kransdorf M, Murphey M. Giant cell tumor. In: Davies M, Sundaram M, James S, editors. Imaging of bone tumors and tumor-like lesions. Berlin: Springer; 2009. p. 321–36.
Dahlin DC, Cupps RE, Johnson Jr EW. Giant-cell tumor: a study of 195 cases. Cancer. 1970;25(5):1061–70.
Resnick D. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia: Saunders; 1995.
Unni KK, Dahlin DC. Dahlin’s bone tumors: general aspects and data on 11,087 cases. 5th ed. Philadelphia: Lippincott-Raven; 1996.
Guo W, Ji T, Tang X, Yang Y. Outcome of conservative surgery for giant cell tumor of the sacrum. Spine. 2009;34(10):1025–31. doi:10.1097/BRS.0b013e31819d4127.
Thangaraj R, Grimer RJ, Carter SR, Stirling AJ, Spilsbury J, Spooner D. Giant cell tumour of the sacrum: a suggested algorithm for treatment. Eur Spine J. 2010;19(7):1189–94. doi:10.1007/s00586-009-1270-8.
Martin C, McCarthy EF. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature. Iowa Orthop J. 2010;30:69–75.
van der Heijden L, van de Sande MA, van der Geest IC, Schreuder HW, van Royen BJ, Jutte PC, Bramer JA, Oner FC, van Noort-Suijdendorp AP, Kroon HM, Dijkstra PD. Giant cell tumors of the sacrum—a nationwide study on midterm results in 26 patients after intralesional excision. Eur Spine J. 2014;23(9):1949–62. doi:10.1007/s00586-014-3263-5.
Bloem JL, Reidsma II. Bone and soft tissue tumors of hip and pelvis. Eur J Radiol. 2012;81(12):3793–801. doi:10.1016/j.ejrad.2011.03.101.
Saikia B, Goel A, Gupta SK. Fine-needle aspiration cytologic diagnosis of giant-cell tumor of the sacrum presenting as a rectal mass: a case report. Diagn Cytopathol. 2001;24(1):39–41.
Payer M. Neurological manifestation of sacral tumors. Neurosurg Focus. 2003;15(2):E1. doi:10.3171/foc.2003.15.2.1.
Althausen PL, Schneider PD, Bold RJ, Gupta MC, Goodnight Jr JE, Khatri VP. Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine. 2002;27(15):E361–5.
Higuchi T, Taki J, Sumiya H, Kinuya S, Bunko H, Nonomura A, Tsuchiya H, Tonami N. Intense 201 Tl uptake in giant-cell tumour of bone. Nucl Med Commun. 2002;23(6):595–9.
Mavrogenis AF, Patapis P, Kostopanagiotou G, Papagelopoulos PJ. Tumors of the sacrum. Orthopedics. 2009;32(5):342.
van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovee JV, Hogendoorn PC, Gelderblom H. The clinical approach toward giant cell tumor of bone. Oncologist. 2014;19(5):550–61. doi:10.1634/theoncologist.2013-0432.
Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics. 2001;21(5):1283–309. doi:10.1148/radiographics.21.5.g01se251283.
Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk Jr GR. Giant cell tumor of bone: review, mimics, and new developments in treatment. Radiographics. 2013;33(1):197–211. doi:10.1148/rg.331125089.
Manaster BJ, Graham T. Imaging of sacral tumors. Neurosurg Focus. 2003;15(2):E2.
Gerber S, Ollivier L, Leclere J, Vanel D, Missenard G, Brisse H, de Pinieux G, Neuenschwander S. Imaging of sacral tumours. Skeletal Radiol. 2008;37(4):277–89. doi:10.1007/s00256-007-0413-4.
Wang K, Allen L, Fung E, Chan CC, Chan JC, Griffith JF. Bone scintigraphy in common tumors with osteolytic components. Clin Nucl Med. 2005;30(10):655–71.
Levine E, De Smet AA, Neff JR, Martin NL. Scintigraphic evaluation of giant cell tumor of bone. AJR Am J Roentgenol. 1984;143(2):343–8. doi:10.2214/ajr.143.2.343.
Levine E, De Smet AA, Neff JR. Role of radiologic imaging in management planning of giant cell tumor of bone. Skeletal Radiol. 1984;12(2):79–89.
Hosalkar HS, Jones KJ, King JJ, Lackman RD. Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results. Spine. 2007;32(10):1107–15. doi:10.1097/01.brs.0000261558.94247.8d.
Lackman RD, Khoury LD, Esmail A, Donthineni-Rao R. The treatment of sacral giant-cell tumours by serial arterial embolisation. J Bone Joint Surg Br. 2002;84(6):873–7.
Lin PP, Guzel VB, Moura MF, Wallace S, Benjamin RS, Weber KL, Morello Jr FA, Gokaslan ZL, Yasko AW. Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization. Cancer. 2002;95(6):1317–25. doi:10.1002/cncr.10803.
Thomas DM. RANKL, denosumab, and giant cell tumor of bone. Curr Opin Oncol. 2012;24(4):397–403. doi:10.1097/CCO.0b013e328354c129.
Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol. 2002;117(2):210–6. doi:10.1309/BPET-F2PE-P2BD-J3P3.
Liao TS, Yurgelun MB, Chang SS, Zhang HZ, Murakami K, Blaine TA, Parisien MV, Kim W, Winchester RJ, Lee FY. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res. 2005;23(1):203–9. doi:10.1016/j.orthres.2004.06.018.
Rao UN, Goodman M, Chung WW, Swalski P, Pal R, Finkelstein S. Molecular analysis of primary and recurrent giant cell tumors of bone. Cancer Genet Cytogenet. 2005;158(2):126–36. doi:10.1016/j.cancergencyto.2004.09.015.
Gorunova L, Vult von Steyern F, Storlazzi CT, Bjerkehagen B, Folleras G, Heim S, Mandahl N, Mertens F. Cytogenetic analysis of 101 giant cell tumors of bone: nonrandom patterns of telomeric associations and other structural aberrations. Genes Chromosomes Cancer. 2009;48(7):583–602. doi:10.1002/gcc.20667.
Forsyth RG, De Boeck G, Bekaert S, De Meyer T, Taminiau AH, Uyttendaele D, Roels H, Praet MM, Hogendoorn PC. Telomere biology in giant cell tumour of bone. J Pathol. 2008;214(5):555–63. doi:10.1002/path.2301.
Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goody V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR, Campbell PJ, Flanagan AM. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45(12):1479–82. doi:10.1038/ng.2814.
Oda Y, Sakamoto A, Saito T, Matsuda S, Tanaka K, Iwamoto Y, Tsuneyoshi M. Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation. Histopathology. 2001;39(6):629–37.
Saito T, Mitomi H, Izumi H, Suehara Y, Okubo T, Torigoe T, Takagi T, Kaneko K, Sato K, Matsumoto T, Yao T. A case of secondary malignant giant-cell tumor of bone with p53 mutation after long-term follow-up. Hum Pathol. 2011;42(5):727–33. doi:10.1016/j.humpath.2010.08.008.
Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134(9):969–78. doi:10.1007/s00432-008-0370-x.
Sanerkin NG. Malignancy, aggressiveness, and recurrence in giant cell tumor of bone. Cancer. 1980;46(7):1641–9.
Dominkus M, Ruggieri P, Bertoni F, Briccoli A, Picci P, Rocca M, Mercuri M. Histologically verified lung metastases in benign giant cell tumours—14 cases from a single institution. Int Orthop. 2006;30(6):499–504. doi:10.1007/s00264-006-0204-x.
Donthineni R, Boriani L, Ofluoglu O, Bandiera S. Metastatic behaviour of giant cell tumour of the spine. Int Orthop. 2009;33(2):497–501. doi:10.1007/s00264-008-0560-9.
Siebenrock KA, Unni KK, Rock MG. Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br. 1998;80(1):43–7.
Lewis VO. What’s new in musculoskeletal oncology. J Bone Joint Surg Am. 2007;89(6):1399–407. doi:10.2106/JBJS.G.00075.
Mirra JM, Picci P, Gold RH. Bone tumors: clinical, radiologic, and pathologic correlations. Philadelphia: Lea & Febiger; 1989.
Horvai A, Unni KK. Premalignant conditions of bone. J Orthop Sci. 2006;11(4):412–23. doi:10.1007/s00776-006-1037-6.
McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant-cell tumor of bone. J Bone Joint Surg Am. 1986;68(2):235–42.
Turcotte RE, Sim FH, Unni KK. Giant cell tumor of the sacrum. Clin Orthop Relat Res. 1993;291:215–21.
Marcove RC, Sheth DS, Brien EW, Huvos AG, Healey JH. Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision. Cancer. 1994;74(4):1253–60.
Gaztanaga M, Aristu J, Villas C, San-Julian M. Giant cell tumors of the sacrum treated with intralesional resection and radiotherapy: a case series and review of the literature. Eur Orthop Traumatol. 2011;1:175–9.
Li G, Fu D, Chen K, Ma X, Sun M, Sun W, Li J, Cai Z. Surgical strategy for the management of sacral giant cell tumors: a 32-case series. Spine J. 2012;12(6):484–91. doi:10.1016/j.spinee.2012.06.014.
Eftekhari F, Wallace S, Chuang VP, Soo CS, Cangir A, Benjamin RS, Murray JA. Intraarterial management of giant-cell tumors of the spine in children. Pediatr Radiol. 1982;12(6):289–93.
Gottfried ON, Schmidt MH, Stevens EA. Embolization of sacral tumors. Neurosurg Focus. 2003;15(2):E4.
Kollender Y, Meller I, Bickels J, Flusser G, Issakov J, Merimsky O, Marouani N, Nirkin A, Weinbroum AA. Role of adjuvant cryosurgery in intralesional treatment of sacral tumors. Cancer. 2003;97(11):2830–8. doi:10.1002/cncr.11383.
Ozaki T, Liljenqvist U, Halm H, Hillmann A, Gosheger G, Winkelmann W. Giant cell tumor of the spine. Clin Orthop Relat Res. 2002;401:194–201.
Persson BM, Ekelund L, Lovdahl R, Gunterberg B. Favourable results of acrylic cementation for giant cell tumors. Acta Orthop Scand. 1984;55(2):209–14.
Raque Jr GH, Vitaz TW, Shields CB. Treatment of neoplastic diseases of the sacrum. J Surg Oncol. 2001;76(4):301–7.
Sar C, Eralp L. Surgical treatment of primary tumors of the sacrum. Arch Orthop Trauma Surg. 2002;122(3):148–55. doi:10.1007/s00402-001-0356-5.
Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Folleras G. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008;79(1):86–93. doi:10.1080/17453670710014815.
Algawahmed H, Turcotte R, Farrokhyar F, Ghert M. High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis. Sarcoma. 2010; doi:10.1155/2010/586090.
Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M. Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev. 2010;36(1):1–7. doi:10.1016/j.ctrv.2009.09.002.
Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011;469(2):591–9. doi:10.1007/s11999-010-1501-7.
Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol. 2001;27(2):200–2. doi:10.1053/ejso.2000.1086.
Gaston CL, Bhumbra R, Watanuki M, Abudu AT, Carter SR, Jeys LM, Tillman RM, Grimer RJ. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br. 2011;93(12):1665–9. doi:10.1302/0301-620X.93B12.27663.
Wuisman P, Lieshout O, Sugihara S, van Dijk M. Total sacrectomy and reconstruction: oncologic and functional outcome. Clin Orthop Relat Res. 2000;381:192–203.
Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, Kroep J, Grimer R, Reichardt P, Rutkowski P, Schuetze S, Skubitz K, Staddon A, Thomas D, Qian Y, Jacobs I. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol. 2013;14(9):901–8. doi:10.1016/S1470-2045(13)70277-8.
Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11(3):275–80. doi:10.1016/S1470-2045(10)70010-3.
Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, Gibbs Jr CP, Mendenhall WM, Zlotecki RA. Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol. 2013;36(5):505–8. doi:10.1097/COC.0b013e3182568fb6.
Ruka W, Rutkowski P, Morysinski T, Nowecki Z, Zdzienicki M, Makula D, Ptaszynski K, Bylina E, Grzesiakowska U. The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of bone. Int J Radiat Oncol Biol Phys. 2010;78(2):494–8. doi:10.1016/j.ijrobp.2009.07.1704.
Conflict-of-Interest Statement
No benefits have been or will be received from a commercial party related directly or indirectly to the subject matter of this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Mavrogenis, A.F., Panagopoulos, G.N., Angelini, A., Ruggieri, P. (2017). Giant Cell Tumor of the Sacrum. In: Ruggieri, P., Angelini, A., Vanel, D., Picci, P. (eds) Tumors of the Sacrum. Springer, Cham. https://doi.org/10.1007/978-3-319-51202-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-51202-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51200-6
Online ISBN: 978-3-319-51202-0
eBook Packages: MedicineMedicine (R0)